Didn't Kenny promise a CT by the end of 2016? Or before that wasn't it Q3 2015? Whatever happened to those CTs in Australia in 2012? The proof is in the history of this scam.
The reader is invited to try to find a Nasdaq small-cap biotech with no pipeline, no products marketed, with 2B+ shares in the O/S. Or for that matter one with an O/S of 1B. Dilutionary SCAM!
fda doesn't think its a scam!
It is not the FDA's function to determine if a Microcrap scam submitting an IND is a scam or not. The FDA regulates. In this case they placed a Hold on a deficient IND.
FDA has put a HOLD on the IND submission. They may not think this is a scam because their job is not scam deciding. Their job is to look at all that is presented to them, all study related data. They will not deduce this as a scam.
News 
Market Data 
Discover 
